MCAT and breast carcinoma: However, there is a paucity of studies evaluating the immunohistochemical expression of MT in breast cancer, and to the best of our knowledge, only one published study in the literature has compared the expression of MT-1 between women with breast cancer and women with fibroadenoma14.